• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS CHOL2 CHOLESTEROL GEN.2; ENZYMATIC ESTERASE--OXIDASE, CHOLESTEROL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS CHOL2 CHOLESTEROL GEN.2; ENZYMATIC ESTERASE--OXIDASE, CHOLESTEROL Back to Search Results
Catalog Number 05168538190
Device Problem Non Reproducible Results (4029)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 07/02/2019
Event Type  malfunction  
Manufacturer Narrative
The customer stated that they have seen this issue for a year.The customer believes the issue is resolved by either high centrifugation of the patient samples or letting the patient samples sit for greater than 24 hours.The customer considers the results obtained after performing these steps more consistent with the patient's clinical pictures and historical results.The investigation is currently ongoing.The event occurred in: (b)(6).
 
Event Description
The initial reporter complained of questionable results for multiple patients from two cobas 8000 c 702 modules and one cobas 6000 c (501) module.The customer believes that the patient's results are being affected by lipemia in the blood sample.From the data provided: 3 patients had questionable crej2 creatinine jaffé gen.2, trigl triglycerides, and chol2 cholesterol gen.2 results.1 patient had questionable crej2 and trigl results.6 patients had questionable crej2 results.1 patient had questionable hdlc4 hdl-cholesterol plus 4th generation, trigl, and chol2 results.2 patients had questionable trigl results.5 patients had questionable trigl and chol2 results.The date of the event is the earliest known date that a questionable patient result was obtained.The customer indicated that this has been an ongoing issue.This medwatch will cover chol2.For crej2, hdlc4, and trigl refer to the med watches with patient identifiers (b)(6) respectively.The customer verified that there was no allegation of any adverse events for any patients.The customer did not specify which results were from which analyzers.But they did provide the following instrument serial numbers: cobas c702 (b)(4), cobas c702 (b)(4), and cobas c501 (b)(4).
 
Manufacturer Narrative
The investigation did not identify a product problem.The cause of the event could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CHOL2 CHOLESTEROL GEN.2
Type of Device
ENZYMATIC ESTERASE--OXIDASE, CHOLESTEROL
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key9075461
MDR Text Key216358392
Report Number1823260-2019-03316
Device Sequence Number1
Product Code CHH
Combination Product (y/n)N
PMA/PMN Number
K031824
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 03/04/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/17/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number05168538190
Device Lot NumberASKU
Was Device Available for Evaluation? Yes
Date Manufacturer Received08/23/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-